about
Ovarian tumor cells express a novel multi-domain cell surface serine proteaseHuman kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancerMore than 15 years of CA 125: what is known about the antigen, its structure and its function.Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes.Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.The frequent shift to intermediate flora in preterm delivery cases after abnormal vaginal flora screening.Clinical features of ovarian large-cell neuroendocrine carcinoma: Four case reports and review of the literature.Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer.[Study on the localization of human papillomavirus DNA in the vulvar disease by means of in situ hybridization].Increased expression of protease M in ovarian tumors.Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.[Antiemetic efficacy of the repeated use of granisetron in multiple cycles of anti-cancer chemotherapy][Detection of HPV type 16 early genes E7 and E5 messenger RNA in uterine cervical neoplasia by reverse transcriptase polymerase chain reaction][Amplified DNA detection of HPV types 16 and 18 E7 gene in uterine cervical neoplasia by polymerase chain reaction][A case report: squamous cell carcinoma of the uterine body][Effect of intravaginal administration of cisplatin (CDDP) suppositories to uterine cervical cancer--blood and tissue concentrations and the therapeutic effects][A case of malignant mesothelioma arising from uterine serosa after radiation therapy in uterine cervical cancer]Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcomaThe stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cellsHepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancerInduction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage diseaseExpression of the farnesyltransferase beta-subunit gene in human ovarian carcinoma: correlation to K-ras mutation[Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer]The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatmentCyclin D1 overexpression and p53 mutation status in epithelial ovarian cancerExpression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein hK8 in uterine endometria and endometrial carcinomasEarly clinical outcomes of 3D-conformal radiotherapy using accelerated hyperfractionation without intracavitary brachytherapy for cervical cancer[A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11+CDDP chemotherapy after non-curative surgery]
P50
Q24290493-09B92816-283B-49B6-A119-EB8250692553Q28257940-A79ADD18-23DA-4F0C-8461-99CA076323D1Q33608460-3F94C94E-D737-4C6F-8F08-D4641301EBD2Q33735099-A8F1FF67-27F4-489D-8D5C-B15CCBA3B415Q34320200-B8BC39C3-A8F3-456C-9EB6-1065F7E3B8B3Q35156830-E865F003-E5C8-460B-BB3D-053586A16FE9Q36230951-7CDD6BA9-81DE-484D-939F-0E5E7B58B59BQ36616173-087F69F9-AD14-4E7E-B939-FDCBF883C5A7Q42027967-C9EC33B9-3033-4A27-9436-13DF652F4DE4Q43508961-6944A7BA-6F8F-4A0E-BE20-2E911242C413Q43925299-1DB84D51-927B-4E55-8B84-00465E86D587Q64981664-F4845C32-A3BF-4150-85D5-74632A41CE9CQ68012341-0C4D12DD-5171-44F1-88F5-1FD311CCFDF2Q68478042-C94A2DAA-A8F2-4C9D-A314-CC4E20B693E1Q72191854-5FDBC62E-AF97-41D7-8CEC-6B1FF6B6560BQ72420359-D5E09D2A-A427-4B57-9A30-5DB2EB394B43Q72813739-93F08C0A-4835-46A1-A263-AE51A83AD1F9Q73081125-1DD9DDEE-2F51-41E6-BEE9-21ABE591C646Q73202335-79E4A490-BEAF-476C-BC04-F818412073E0Q73526544-DFCF0300-96AF-4F08-9E2B-F9098C499653Q73540214-2285E9F0-A84B-4D54-A958-9141B30AFFAFQ73606781-7979B6AA-D067-43BE-9798-744130F88168Q74014766-71CAFE67-B8A0-40F4-9939-8DD563D9724BQ74526128-A0744FF6-1F62-4951-A803-E327A3349BF4Q77332327-2AB1B17F-4DAB-460A-8FD0-D4D1FA80C371Q80058759-A891583B-5C81-4DC7-8CB2-71AB2401224BQ80064305-EDA29851-D902-43D5-86A2-2DF33A753078Q85008292-1826B6B9-3C8A-4253-B3D4-5B2F18EE4861
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Hirotoshi Tanimoto
@en
Tanimoto H
@ast
Tanimoto H
@es
Tanimoto H
@nl
type
label
Hirotoshi Tanimoto
@en
Tanimoto H
@ast
Tanimoto H
@es
Tanimoto H
@nl
altLabel
Tanimoto H
@en
prefLabel
Hirotoshi Tanimoto
@en
Tanimoto H
@ast
Tanimoto H
@es
Tanimoto H
@nl
P31
P496
0000-0002-0463-8760